Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Pelvic Inflammatory Disease (PID)
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 

Self-Study STD Module - PID

Partner Management and Public Health Measures

Partner Management

  • Male sex partners of a woman with PID should be examined and treated if they had sexual contact with the woman during the 60 days preceding onset of symptoms. Such evaluation and treatment are imperative because of the risk for reinfection and the strong likelihood of gonococcal or chlamydial infection in the sex partner.
  • Male partners of women who have PID caused by C. trachomatis or N. gonorrhoeae are often asymptomatic.
  • Sex partners should be treated empirically with regimens effective against both C. trachomatis and N. gonorrhoeae, regardless of the apparent etiology of PID or pathogens isolated from the infected woman.

Click here for a Study Question

Reporting Requirements

Laws and regulations in all states require that persons with gonorrhea or chlamydia be reported to public health authorities by clinicians, labs, or both. Click here for links to state and local public health departments.

Screening

Prevention of chlamydial infection by screening and treating at-risk women reduces the incidence of PID. Chlamydia screening recommendations include annual screening for:

  • Sexually active women age 25 and younger
  • Sexually active women over age 25 at high risk
  • Pregnant women in the first trimester, or at the first prenatal visit if after the first trimester
  • Any patient diagnosed with another STD

Screening for and treatment of BV prior to upper reproductive tract invasive or surgical procedures (e.g., abortion or hysterectomy) is a prevention strategy recommended by some experts.

Click here for a Study Question

Page 10 of 13 BackStatusStatusNext



Page last modified: June 3, 2009
Page last reviewed: June 3, 2009

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention